Abstract: The present disclosure relates generally to alloys, and in particular, to iron alloys.

Abstract: Antimicrobial compositions including at least one acid and at least one anionic surfactant are provided. In particular, food contact antimicrobial compositions including at least one acid and at least one anionic surfactant provide a no-rinse compositions efficacious against Norovirus, having acceptable use solution pH that do not require use of personal protective equipment (PPE), are surface compatible and do not leave residues on treated surfaces are provided. Methods of cleaning a surface with the compositions are also provided.

Abstract: A method comprises storing first transaction data for a first transaction producing a first version of a first dataset, second transaction data for a second transaction transforming a first version of the first dataset to a second version of the first dataset, and third transaction data for a third transaction transforming the second version of the first dataset to a third version of the first dataset; storing dependency information indicating a first dependency of the third transaction on the second transaction and a second dependency of the second transaction on the first transaction; receiving a first instruction to revoke a first permission of a first user to access the second version of the first dataset; automatically revoking a certain permission of the first user to access the third version of the first dataset based on the dependency information.

Abstract: Antimicrobial compositions including at least one acid and at least one anionic surfactant are provided. In particular, food contact antimicrobial compositions including at least one acid and at least one anionic surfactant provide efficacious virucidal activity, including against Norovirus, having acceptable use solution pH that do not require use of personal protective equipment (PPE), are surface compatible and do not leave residues on treated surfaces. Methods of cleaning a surface with the compositions are also provided and may beneficially eliminate the need to rinse the antimicrobial compositions after use.

Abstract: The present invention is directed to plants that display a pathogen resistance and increased drought tolerance phenotype due to altered expression of a PRDT1 nucleic acid. The invention is further directed to methods of generating plants with a pathogen resistance and increased drought tolerance phenotype.

Abstract: The present invention is directed to plants that display a drought tolerance phenotype due to altered expression of a DR05 nucleic acid. The invention is further directed to methods of generating plants with a drought tolerance phenotype.

Abstract: The present invention is directed to plants that display a pathogen resistance and increased drought tolerance phenotype due to altered expression of a PRDT1 nucleic acid. The invention is further directed to methods of generating plants with a pathogen resistance and increased drought tolerance phenotype.

Abstract: The present invention is directed to plants that display a pathogen resistance and increased drought tolerance phenotype due to altered expression of a PRDT1 nucleic acid. The invention is further directed to methods of generating plants with a pathogen resistance and increased drought tolerance phenotype.

Abstract: The present invention is directed to plants that display a drought tolerance phenotype due to altered expression of a DRO3 nucleic acid. The invention is further directed to methods of generating plants with a drought tolerance phenotype.

Abstract: The present invention is directed to plants that display a pathogen resistance and increased drought tolerance phenotype due to altered expression of a PRDT1 nucleic acid. The invention is further directed to methods of generating plants with a pathogen resistance and increased drought tolerance phenotype.

Abstract: The present invention is directed to plants that display a drought tolerance phenotype due to altered expression of a DR03 nucleic acid. The invention is further directed to methods of generating plants with a drought tolerance phenotype.

Abstract: The present invention is directed to plants that display a drought tolerance phenotype due to altered expression of a DR05 nucleic acid. The invention is further directed to methods of generating plants with a drought tolerance phenotype.

Abstract: The present invention is directed to plants that display a pathogen resistance and increased drought tolerance phenotype due to altered expression of a PRDT1 nucleic acid. The invention is further directed to methods of generating plants with a pathogen resistance and increased drought tolerance phenotype.

Abstract: A method for the identification of compounds as inhibitors of oncoprotein action is described. A compound is identified as an inhibitor of oncoprotein action based on its ability to modulate the transcription of a reporter gene. Transcription of the reporter gene is dependent upon the binding of a fusion oncoprotein to a specific DNA binding element positioned upstream of the reporter gene promoter. The fusion oncoprotein contains a transcriptional regulatory domain from an oncoprotein and a DNA binding domain from a different protein.

Abstract: A self-supporting, two-legged figure includes an armature with leg wires of stiffly bendable material, extending a substantial distance into the torso preferably at least 3/4 of the way to the head end of the torso a body supported by the leg wires and feet assemblies fixedly connected to a lower end of each of the leg wires. The body includes a head, hands, a torso and arms that may be part of the hands. The head and hands are made of clay, and are generally at least twice as heavy as the torso, making the figure top-heavy. At least one of the feet assemblies has a lower surface for engaging a support surface but independent of the support surface. The feet assemblies weigh more than the entire rest of the figure, and have an effective support surface-engaging area to support the body in an erect or standing condition.

Abstract: A method of graphically displaying cardiopulmonary function data by providing a plurality of axes radially projecting from a common point of origin, there being one such axis for each cardiopulmonary parameter to be plotted, each axis having scale markings thereon whereby the normal value for each parameter will lie an equal distance from said point of origin, and straight line segments connected between said normal values on adjacent axes will form a generally regular polygon. The cardiopulmonary function data to be displayed are then plotted on the same appropriate axis and to the same scale such that deviations of any such data from normal will result in an irregular polygon when the segments are joined between plotted values on adjacent axis. Deviations of the irregular polygon from the regular polygon thus provides a clinician with a readily visible display of possible cardiopulmonary disfunction.

Abstract: A cardiopulmonary exercise system for real-time, breath-by-breath acquisition, analysis, display and printing of an individual's physiologic parameters. A microprocessor based waveform analyzer receives inputs from a CO.sub.2 analyzer, an ECG monitor, an O.sub.2 analyzer, and a pneumotachograph, and, optionally, can also connect a cycle ergometer, a treadmill, a cardiac stress system, and an ear oximeter. The waveform analyzer provides output data to a host central processor unit to which a CRT display, a graphics copier or hard-copy printer may be connected for providing medical data for assessment of an individual's heart and lungs, on a real-time basis whereby the level of fitness or underlying organic defects which may effect the cardiopulmonary system can be determined. The pneumotachograph, CO.sub.2 analyzer and O.sub.2 analyzer and ECG monitor provide analog signals representing flow, CO.sub.2 and O.sub.2 levels in expired air as well as heart rate.

Abstract: A system for measuring the ventilatory response of the human respiratory system to increased levels of CO.sub.2 and/or decreased levels of O.sub.2. Measured concentrations of CO.sub.2 are introduced into an infant's lungs and the inspired and expired air is passed through a pneumotachograph for developing various electrical analog signals relating to flow. Samples of the expired air are delivered to CO.sub.2 and O.sub.2 analyzers. The resulting electrical analog signals produced by these devices represent inspiratory and expiratory flow, and the CO.sub.2 and the O.sub.2 levels in the expired air. They are applied to a waveform analyzer containing an analog to digital converter and a microprocessor system which is programmed to discriminate between normal breathing patterns and irregular patterns. The microprocessor also computes inspiratory and expiratory tidal volume, ventilation (measured in liters per minute), breathing frequency, inspiratory, expiratory and total times of a preceding breath, minimum CO.